Patent · US Active

Fully human therapeutic antibodies specific for human CD38

US9193799B2 · kind B2 · utility

3Cited by

5References

40Claims

0Family size

Assignee

MORPHOSYS AG · DE

Inventors

Michael Tesar · Heidelberg, DE
Ute Jäger · Höchst im Odenwald, DE

Key dates

Filing date	Jun 14, 2013
Grant date	Nov 24, 2015
Priority date	—
Expiry date	Aug 12, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/732
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention nucleic acids encoding novel antibodies and functional fragments thereof specific for CD38. Such antibodies are useful for the treatment of diseases associated with CD38 expression, including hematological malignancies such as multiple myeloma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.